NVAX logo

Novavax (NVAX) Current Liabilities

Annual Current Liabilities

$1.64 B
-$824.81 M-33.53%

December 31, 2023


Summary


Performance

NVAX Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXbalance sheetmetrics:

Quarterly Current Liabilities

$1.18 B
+$23.19 M+2.00%

September 30, 2024


Summary


Performance

NVAX Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

NVAX Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-33.5%-19.6%
3 y3 years+182.1%-50.6%
5 y5 years+3490.6%+6121.7%

NVAX Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-33.5%at low-52.0%+46.8%
5 y5-year-33.5%+6239.0%-52.0%+6121.7%
alltimeall time-33.5%>+9999.0%-52.0%>+9999.0%

Novavax Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$1.18 B(+2.0%)
Jun 2024
-
$1.16 B(+43.9%)
Mar 2024
-
$804.38 M(-50.8%)
Dec 2023
$1.64 B(-33.5%)
$1.64 B(+11.3%)
Sep 2023
-
$1.47 B(-8.0%)
Jun 2023
-
$1.60 B(-16.8%)
Mar 2023
-
$1.92 B(-22.0%)
Dec 2022
$2.46 B(+2.9%)
$2.46 B(+47.5%)
Sep 2022
-
$1.67 B(-22.6%)
Jun 2022
-
$2.16 B(-4.6%)
Mar 2022
-
$2.26 B(-5.4%)
Dec 2021
$2.39 B(+312.4%)
$2.39 B(+36.3%)
Sep 2021
-
$1.75 B(+6.2%)
Jun 2021
-
$1.65 B(+36.7%)
Mar 2021
-
$1.21 B(+108.5%)
Dec 2020
$579.67 M(+2147.2%)
$579.67 M(+142.3%)
Sep 2020
-
$239.22 M(+12.1%)
Jun 2020
-
$213.33 M(+1023.9%)
Mar 2020
-
$18.98 M(-26.4%)
Dec 2019
$25.80 M(-43.4%)
$25.80 M(+19.6%)
Sep 2019
-
$21.57 M(-48.0%)
Jun 2019
-
$41.49 M(+31.7%)
Mar 2019
-
$31.50 M(-30.8%)
Dec 2018
$45.54 M(-38.2%)
$45.54 M(-2.5%)
Sep 2018
-
$46.72 M(+8.6%)
Jun 2018
-
$43.02 M(-4.2%)
Mar 2018
-
$44.90 M(-39.1%)
Dec 2017
$73.67 M(+10.9%)
$73.67 M(+7.9%)
Sep 2017
-
$68.28 M(+2.2%)
Jun 2017
-
$66.79 M(+18.2%)
Mar 2017
-
$56.50 M(-14.9%)
Dec 2016
$66.41 M(-13.2%)
$66.41 M(-12.3%)
Sep 2016
-
$75.68 M(-7.6%)
Jun 2016
-
$81.88 M(+15.2%)
Mar 2016
-
$71.05 M(-7.1%)
Dec 2015
$76.49 M(+124.2%)
$76.49 M(+207.5%)
Sep 2015
-
$24.87 M(-8.1%)
Jun 2015
-
$27.05 M(-6.0%)
Mar 2015
-
$28.78 M(-15.7%)
Dec 2014
$34.12 M(+88.3%)
$34.12 M(+83.1%)
Sep 2014
-
$18.64 M(+6.6%)
Jun 2014
-
$17.48 M(+27.4%)
Mar 2014
-
$13.71 M(-24.3%)
Dec 2013
$18.12 M(+55.2%)
$18.12 M(+27.1%)
Sep 2013
-
$14.26 M(+26.7%)
Jun 2013
-
$11.26 M(+21.6%)
Mar 2013
-
$9.25 M(-20.7%)
Dec 2012
$11.68 M(+54.0%)
$11.68 M(+11.8%)
Sep 2012
-
$10.44 M(+10.8%)
Jun 2012
-
$9.42 M(+20.2%)
Mar 2012
-
$7.84 M(+3.5%)
Dec 2011
$7.58 M(-26.2%)
$7.58 M(+12.4%)
Sep 2011
-
$6.74 M(-25.1%)
Jun 2011
-
$8.99 M(-19.2%)
Mar 2011
-
$11.13 M(+8.4%)
Dec 2010
$10.27 M
$10.27 M(+7.7%)
Sep 2010
-
$9.53 M(+11.8%)
DateAnnualQuarterly
Jun 2010
-
$8.52 M(-7.7%)
Mar 2010
-
$9.23 M(+15.0%)
Dec 2009
$8.03 M(-71.0%)
$8.03 M(+42.1%)
Sep 2009
-
$5.65 M(-44.6%)
Jun 2009
-
$10.19 M(-62.0%)
Mar 2009
-
$26.83 M(-3.2%)
Dec 2008
$27.72 M(+346.6%)
$27.72 M(-8.2%)
Sep 2008
-
$30.18 M(+234.3%)
Jun 2008
-
$9.03 M(+8.5%)
Mar 2008
-
$8.32 M(+34.1%)
Dec 2007
$6.21 M(+16.2%)
$6.21 M(+10.5%)
Sep 2007
-
$5.62 M(-0.5%)
Jun 2007
-
$5.64 M(-0.5%)
Mar 2007
-
$5.67 M(+6.3%)
Dec 2006
$5.34 M(+9.5%)
$5.34 M(+47.6%)
Sep 2006
-
$3.62 M(-10.3%)
Jun 2006
-
$4.03 M(+13.8%)
Mar 2006
-
$3.54 M(-27.3%)
Dec 2005
$4.88 M(-43.1%)
$4.88 M(+3.6%)
Sep 2005
-
$4.71 M(-16.4%)
Jun 2005
-
$5.63 M(-8.1%)
Mar 2005
-
$6.13 M(-28.5%)
Dec 2004
$8.58 M(+77.3%)
$8.58 M(+9.3%)
Sep 2004
-
$7.84 M(-3.3%)
Jun 2004
-
$8.11 M(+69.8%)
Mar 2004
-
$4.78 M(-1.2%)
Dec 2003
$4.84 M(-17.5%)
$4.84 M(-7.9%)
Sep 2003
-
$5.25 M(+25.2%)
Jun 2003
-
$4.19 M(-8.8%)
Mar 2003
-
$4.59 M(-21.7%)
Dec 2002
$5.86 M(-16.2%)
$5.86 M(-13.2%)
Sep 2002
-
$6.76 M(-13.1%)
Jun 2002
-
$7.77 M(+6.5%)
Mar 2002
-
$7.30 M(+4.3%)
Dec 2001
$7.00 M(+48.7%)
$7.00 M(+13.9%)
Sep 2001
-
$6.14 M(+14.8%)
Jun 2001
-
$5.35 M(+31.9%)
Mar 2001
-
$4.06 M(-13.8%)
Dec 2000
$4.71 M(+194.1%)
$4.71 M(+132.1%)
Sep 2000
-
$2.03 M(+18.3%)
Jun 2000
-
$1.71 M(+21.9%)
Mar 2000
-
$1.41 M(-12.1%)
Dec 1999
$1.60 M(+77.8%)
$1.60 M(+77.8%)
Sep 1999
-
$900.00 K(+200.0%)
Jun 1999
-
$300.00 K(-66.7%)
Mar 1999
-
$900.00 K(0.0%)
Dec 1998
$900.00 K(+200.0%)
$900.00 K(+350.0%)
Sep 1998
-
$200.00 K(-33.3%)
Jun 1998
-
$300.00 K(0.0%)
Mar 1998
-
$300.00 K(0.0%)
Dec 1997
$300.00 K(-50.0%)
$300.00 K(+50.0%)
Sep 1997
-
$200.00 K(-50.0%)
Jun 1997
-
$400.00 K(0.0%)
Mar 1997
-
$400.00 K(-33.3%)
Dec 1996
$600.00 K
$600.00 K(+50.0%)
Sep 1996
-
$400.00 K(-20.0%)
Jun 1996
-
$500.00 K(0.0%)
Mar 1996
-
$500.00 K

FAQ

  • What is Novavax annual total current liabilities?
  • What is the all time high annual current liabilities for Novavax?
  • What is Novavax annual current liabilities year-on-year change?
  • What is Novavax quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Novavax?
  • What is Novavax quarterly current liabilities year-on-year change?

What is Novavax annual total current liabilities?

The current annual current liabilities of NVAX is $1.64 B

What is the all time high annual current liabilities for Novavax?

Novavax all-time high annual total current liabilities is $2.46 B

What is Novavax annual current liabilities year-on-year change?

Over the past year, NVAX annual total current liabilities has changed by -$824.81 M (-33.53%)

What is Novavax quarterly total current liabilities?

The current quarterly current liabilities of NVAX is $1.18 B

What is the all time high quarterly current liabilities for Novavax?

Novavax all-time high quarterly total current liabilities is $2.46 B

What is Novavax quarterly current liabilities year-on-year change?

Over the past year, NVAX quarterly total current liabilities has changed by -$287.59 M (-19.58%)